ALNYLAM PHARMACEUTICALS, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: (617) 551-8200
CIK: 0001178670
EIN: 770602661
State Location: MA
Tickers:
  • Nasdaq:ALNY

Form: 10-Q

Filing Date: 30 Apr 2026
Report Date: 31 Mar 2026
Accepted: 30 Apr 2026 06:16 a.m.
Accession Number: 0001628280-26-028605
Act: 34
File Number: 001-36407
Film Number: 26920246

Documents

Primary Document: 10-Q
Accepted: 30 Apr 2026 06:16 a.m.